Cadila Healthcare submits press release

18 Nov 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated November 18, 2019 titled ‘Zydus announces second Phase 3 trial of Desidustat’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

887.55 -9.05 (-1.01%)
29-Jan-2026 13:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1599.40
Dr. Reddys Lab 1201.45
Cipla 1318.55
Zydus Lifesciences 887.55
Lupin 2120.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×